Article Listing - Sanofi facing generic Taxotere competition in USA; first biosimilar cleared in Australia

GLOBAL MARKETS AND FACTORS FOR SUCCESS

6 April 1992

As the geographical borders between pharmaceutical markets begin to disappear, so do the differences among the critical success factors for...

NIGERIAN HEALTH SPENDING FOR 1992

6 April 1992

The federal government of Nigeria has announced a total figure for health care spending in 1992 of 192 million naira,...

ARES-SERONO GAINS RIGHTS TO CUROSURF

6 April 1992

Swiss pharmaceutical group Ares-Serono has acquired exclusive marketing rights in most European territories for a natural pulmonary surfactant product, Curosurf,...

PHARMA COs TOP R&D SPEND IN JAPAN

6 April 1992

Of 16 Japanese companies planning to spend over 10% of their sales on R&D in 1992, nine are pharmaceutical companies,...

NEW EDITOR OF D&TB

6 April 1992

Joe Collier, reader and consultant in clinical pharmacology at St George's Hospital Medical School, London, has been appointed editor of...

AUSTRALIAN PMA: MEG MIDDLETON

6 April 1992

Meg Middleton has been appointed public affairs manager for the Australian Pharmaceu-tical Manufacturers Associa-tion, in succession to Wendy Edwards.

COMPANY NEWS FROM CHINA

6 April 1992

The Shanghai Medicines and Health Products Import and Export Corporation of China exported products worth $150 million in 1991, reports...

NEW US IMPLANT REGULATIONS

6 April 1992

The US Food and Drug Adminis-ration plans to require manufacturers of high-risk medical devices to track new patients closely, so...

CORTECS' NSAID TARGETING STRATEGY

6 April 1992

Researchers at UK-based Cortecs Limited have published results of studies in volunteers concerning its technology aimed at improving the bioavailability...

GERMAN POLICY UNDER FIRE

6 April 1992

German Health Minister Gerda Hasselfeldt has accused the leading German doctors' organization, the Hartmannbund, of political agitation, after it held...

Showing 94491-94500 of 95321 articles